Filter News
Area of Research
- (-) Materials (18)
- (-) Nuclear Science and Technology (7)
- Advanced Manufacturing (1)
- Biology and Environment (5)
- Clean Energy (8)
- Computer Science (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (1)
- Isotopes (1)
- Materials for Computing (1)
- National Security (1)
- Neutron Science (8)
- Supercomputing (7)
News Topics
- (-) Biomedical (1)
- (-) Climate Change (1)
- (-) Fusion (1)
- (-) Isotopes (4)
- (-) Materials Science (15)
- (-) Nuclear Energy (6)
- (-) Polymers (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (2)
- Artificial Intelligence (1)
- Bioenergy (4)
- Chemical Sciences (2)
- Composites (1)
- Computer Science (6)
- Critical Materials (2)
- Decarbonization (1)
- Energy Storage (4)
- Environment (2)
- Machine Learning (1)
- Materials (1)
- Microscopy (3)
- Molten Salt (1)
- Nanotechnology (11)
- National Security (1)
- Neutron Science (9)
- Physics (6)
- Quantum Science (4)
- Space Exploration (1)
- Summit (1)
- Sustainable Energy (5)
- Transformational Challenge Reactor (1)
- Transportation (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists at the Department of Energy’s Oak Ridge National Laboratory used neutrons, isotopes and simulations to “see” the atomic structure of a saturated solution and found evidence supporting one of two competing hypotheses about how ions come
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.